Additionally, mechanistic investigations into how MAGI2-AS3 modulates immune cell function and tumor-immune interactions will be essential to translate these findings into targeted therapeutic strategies, ultimately advancing precision medicine in breast cancer management. This evidence concerns the gene PDS5B and breast cancer.